Clinical Trial Update: A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer [Phase 1]

View source ↗

Summary

A first-in-human Phase 1 study of TORL-4-500 for advanced cancers is currently recruiting, including hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• TORL-4-500

Snippet

Sponsor: TORL Biotherapeutics, LLC | Conditions: Advanced Solid Tumor, Hepatocellular Carcinoma | Phase 1 | Status: RECRUITING